Phibro Animal Health
PAHC
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
0
In their latest 13F (Q3 2026)
See who
Value held
$0k
Combined value at quarter end
Last quarter
0 bought
1 sold or trimmed
Price at Q1 ’26 end
$55.31
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
0Q3 ’25
0Q4 ’25
1Q1 ’26
0Q2 ’26
0Q3 ’26
Who holds it
No manager on this site held it in their latest 13F.
About the company
- Sector
- Health care · Pharmaceutical Preparations
- Incorporated in
- Delaware
- Financial year ends
- 30 June
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$692mJun ’14
$752mJun ’16
$820mJun ’18
$800mJun ’20
$942mJun ’22
$1.0bnJun ’24
$1.5bnJun ’26
| Year | Revenue | Net income |
|---|---|---|
| Year to Jun 2026 | $1.5bn | $99.7m |
| Year to Jun 2025 | $1.3bn | $48.3m |
| Year to Jun 2024 | $1.0bn | $2.4m |
| Year to Jun 2023 | $978m | $32.6m |
| Year to Jun 2022 | $942m | $49.2m |
| Year to Jun 2021 | $833m | $54.4m |
| Year to Jun 2020 | $800m | $33.6m |
| Year to Jun 2019 | $828m | $54.7m |
| Year to Jun 2018 | $820m | $64.9m |
| Year to Jun 2017 | $764m | $64.6m |
| Year to Jun 2016 | $752m | $82.7m |
| Year to Jun 2015 | $749m | $60.3m |
| Year to Jun 2014 | $692m | −$3.1m |
| Year to Jun 2013 | $653m | $24.9m |
Sold out last quarter
- Polen Capital Management in Q2 2026